SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : ProMetic Life Sciences
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: axial who wrote (15)10/12/2016 1:16:46 PM
From: Cush  Read Replies (1) of 250
 
Just listened to the CC regarding the early results for this Alstrom treatment.

Only based on 5 patients, but none-the-less stunning results so far.

As mentioned in the CC, treating these severely ill patients, one might hope to slow or even stop the disease's progression. Stopping the continuing growth of fibrosis in the liver would be remarkable.

However, not only has the fibrosis growth stopped; it appears that those 5 patients are showing a reversal of the existing fibrosis. That's major. Pretty exciting.
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News